1 completed, 1 terminated. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Completed 1, Terminated 1 |
Follow Sarcoma, Kaposi: new trials by email Literature Review of Sarcoma, Kaposi trials Research Report on Sarcoma, Kaposi
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intra-lesional Nivolumab Therapy for Limited Cutaneous Kaposi Sarcoma Nivolumab - Kaposi Sarcoma, HIV/AIDS | Early Phase 1 | Completed | University of California, San Francisco | 12 | 2018-05-07 | 2024-06-25 |
| Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors Nelfinavir - Non-Hodgkin Lymphoma, Hodgkin Lymphoma | Early Phase 1 | Terminated | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1 | 2014-07-01 | 2016-06-10 |
Acquired Immunodeficiency Syndrome (1) · Castleman Disease (1) · Hodgkin Disease (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Nasopharyngeal Neoplasms (1) · Neoplasms (1) · Sarcoma (1) · Stomach Neoplasms (1)
DNA Virus Infections (2) · Herpesviridae Infections (2) · Immune System Diseases (2) · Infections (2) · Neoplasms by Histologic Type (2) · Neoplasms, Connective and Soft Tissue (2) · Neoplasms, Vascular Tissue (2) · Virus Diseases (2) · Blood-Borne Infections (1) · Communicable Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Genital Diseases (1)
Nelfinavir (1) · Nivolumab (1)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1) · University of California, San Francisco (1)
United States (2)
Chia-ching Wang, MD (1) · Richard Ambinder, MD (1)
P30CA082103 (1)